Is this you? Create Your Porfile
Avatar

Van Der Bruggen Pierre

Ludwig Institute for Cancer Research

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Van Der Bruggen Pierre is active.

Explore More

Publication

Featured researches published by Van Der Bruggen Pierre.

Archive | 1995

Method for producing cytolytic t cells specific for a complex of peptide and mhc-molecule

Coulie Pierre; Van Der Bruggen Pierre; Boon-Falleur Thierry

Archive | 2013

ΑΝΟΣΟΓΟΝΙΚΑ ΠΟΛΥΠΕΠΤΙΔΙΑ ΚΩΔΙΚΟΠΟΙΟΥΜΕΝΑ ΑΠΟ ΜΙΝΙΓΟΝΙΔΙΑ MAGE ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ

Berinstein Neil; Tartaglia Jim; Tine John A; Moingeon Philippe; Boon-Falleur Thierry; Van Der Bruggen Pierre

Archive | 2010

MAGE-A1 PEPTIDE DIE VON KLASSE II HLA MOLEKULE PRESENTIERT WERDEN

Van Snick Jacques; Lethe Bernard; Chaux Pascal; Boon-Falleur Thierry; Van Der Bruggen Pierre

Archive | 2008

MAGE-A1 PEPTIDE PRESENTED BY HLA CLASS II MOLECULE

Van Snick Jacques; Lethe Bernard; Chaux Pascal; Boon-Falleur Thierry; Van Der Bruggen Pierre

Archive | 2007

POLIPEPTIDOS INMUNOGENOS CODIFICADOS POR MINIGENES MAGE Y SUS UTILIZACIONES.

Berinstein Neil; Tartaglia Jim; Tine John A; Moingeon Philippe; Boon-Falleur Thierry; Van Der Bruggen Pierre

Archive | 2007

Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf

Tartaglia Jim; Berinstein Neil; Tine John A; Moingeon Philippe; Boon-Falleur Thierry; Van Der Bruggen Pierre

Archive | 2006

Kasvaimen hyljintäantigeenin esiasteet, kasvaimen hyljintäantigeenit ja niiden käytöt

Boon Thierry; Van Der Bruggen Pierre; Van Den Eynde Benoit; Van Pel Aline; De Plaen Etienne; Lurquin Christophe; Chomez Patrick; Traversari Catia

Archive | 2005

PRECURSORES DE ANTIGENOS DE RECHAZO TUMORAL, ANTIGENOS DE RECHAZO TUMORAL Y SUS USOS.

Boon Thierry; Van Der Bruggen Pierre; Van Den Eynde Benoit; Van Pel Aline; De Plaen Etienne; Lurquin Christophe

Archive | 2003

Isolerede, trunkerede nukleinsyremolekyler, som koder for GAGE-tumorafstødningsantigen

Boon-Falleur Thierry; Van Der Bruggen Pierre; Van Den Eynde Benoit; Debacker Olivier

Archive | 2003

MOLECULA DE ACIDO NUCLEICO AISLADA Y TRUNCADA, QUE CODIFICA EL ANTIGENO DE RECHAZO TUMURALL GAGE.

Van Der Bruggen Pierre; Van Den Eynde Benoit; Debacker Olivier; Boon-Falleur Thierry

Explore More

Collaboration

Dive into the Van Der Bruggen Pierre's collaboration.

Top Co-Authors
Avatar

Boon-Falleur Thierry

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

De Plaen Etienne

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Traversari Catia

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Coulie Pierre

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Lurquin Christophe

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Lethe Bernard

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Van Pel Aline

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Chen Yao-Tseng

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Herman Jean

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Chen Yachi

Memorial Sloan Kettering Cancer Center

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge